Skip to main content
Biotest Aktiengesellschaft (FRA:BIO)
Germany flag Germany · Delayed Price · Currency is EUR
42.60
0.00 (0.00%)
At close: May 9, 2025, 10:00 PM CET

FRA:BIO Revenue

Biotest Aktiengesellschaft had revenue of 124.20M EUR in the quarter ending March 31, 2025, a decrease of -42.29%. This brings the company's revenue in the last twelve months to 635.20M, down -18.83% year-over-year. In the year 2024, Biotest Aktiengesellschaft had annual revenue of 726.20M with 6.08% growth.

Revenue (ttm)
635.20M
Revenue Growth
-18.83%
P/S Ratio
2.27
Revenue / Employee
254.59K
Employees
2,495
Market Cap
1.44B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024726.20M41.60M6.08%
Dec 31, 2023684.60M168.50M32.65%
Dec 31, 2022516.10M500.00K0.10%
Dec 31, 2021515.60M31.40M6.48%
Dec 31, 2020484.20M65.10M15.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SAP SE 35.15B
Siemens Aktiengesellschaft 76.54B
Deutsche Telekom AG 118.43B
Allianz SE 107.35B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München 61.15B
Rheinmetall AG 10.48B
Siemens Energy AG 37.44B
Merck KGaA 21.16B
Revenue Rankings

Biotest Aktiengesellschaft News

More News